Clinical Features and Management Challenges in Pediatric Classic CAH from 21-Hydroxylase Deficiency

Overview

Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency presents with variable severity, including salt-wasting and virilization, primarily detected via newborn screening. Management involves glucocorticoid and mineralocorticoid replacement, with ongoing monitoring to address growth, hormonal balance, and psychosocial issues.

Background

Congenital adrenal hyperplasia encompasses autosomal recessive disorders impairing adrenal steroidogenesis, with 21-hydroxylase deficiency (21OHD) being the most common cause. Classic CAH manifests as cortisol and aldosterone deficiency leading to adrenal insufficiency, salt-wasting, and androgen excess causing virilization. Early diagnosis, often through newborn screening, is critical to prevent morbidity and mortality. Treatment aims to replace deficient hormones and suppress excess androgen production.

Data Highlights

Newborn screening for 21OHD began in Alaska in 1978 and is now mandatory in all US states and over 35 countries. First-tier screening uses 17-hydroxyprogesterone (17-OHP) assays standardized by gestational age, with second-tier testing by LC-MS/MS improving sensitivity. False positives are common, necessitating confirmatory testing. Preterm infants have higher baseline 17-OHP levels, requiring gestational age-specific norms.

Key Findings

• Classic CAH is often identified in 46,XX infants due to genital virilization but can be missed in 46,XY infants lacking physical signs.
• Salt-wasting crises can occur if diagnosis is delayed or newborn screening is absent, leading to neonatal morbidity and mortality.
• Glucocorticoid therapy restores cortisol feedback and reduces androgen excess; mineralocorticoid therapy with fludrocortisone and salt supplementation is essential in salt-wasting forms.
• Monitoring includes anthropometric measurements and laboratory assays of adrenal steroids, with special consideration for prematurity affecting steroid levels.
• Psychosocial and surgical considerations are important, especially for 46,XX individuals with genital differences, requiring sensitive communication with families and patients.

Clinical Implications

Early and accurate newborn screening is vital to initiate timely treatment and prevent life-threatening salt-wasting crises. Individualized glucocorticoid and mineralocorticoid replacement, along with careful monitoring of growth and hormone levels, is essential for optimal outcomes. Providers should also address psychosocial aspects and provide family-centered counseling regarding genital differences and management options.

Conclusion

Classic CAH due to 21-hydroxylase deficiency requires multidisciplinary management beginning with newborn screening and confirmatory diagnosis. Comprehensive treatment and monitoring strategies improve clinical outcomes and quality of life for affected children.

References

1. Speiser et al. 2023 -- Clinical Features and Management Difficulties in Pediatric Patients with Classic Congenital Adrenal Hyperplasia Resulting from 21-Hydroxylase Deficiency